Inventor · disambiguated record
Peter Rhode
Also filed as: RHODE PETER · RHODE PETER R
54 granted patents·20 pending applications·2,338 citations·filing 1994–2025
99Inventor score
Files withALTOR BIOSCIENCE LLC39ALTOR BIOSCIENCE CORP17SUNOL MOLECULAR CORP6WONG HING C6IMMUNITYBIO INC2
Top patents by PatentIndex Score
74 records- 0199US11845783B2Multimeric IL-15 soluble fusion molecules and methods of making and using sameALTOR BIOSCIENCE LLC·Filed 2021·Granted Dec 19, 2023·6 cites·5 claims
- 0299US11104716B2Multimeric IL-15 soluble fusion molecules and methods of making and using sameALTOR BIOSCIENCE LLC·Filed 2020·Granted Aug 31, 2021·12 cites·17 claims
- 0399US11046747B2Multimeric IL-15 soluble fusion molecules and methods of making and using sameALTOR BIOSCIENCE LLC·Filed 2020·Granted Jun 29, 2021·18 cites·13 claims
- 0499US10150805B2Multimeric IL-15 soluble fusion molecules and methods of making and using sameALTOR BIOSCIENCE CORP·Filed 2016·Granted Dec 11, 2018·44 cites·20 claims
- 0598US11992516B2Compositions comprising IL-15-based molecules and immune checkpoint inhibitor antibodiesALTOR BIOSCIENCE LLC·Filed 2022·Granted May 28, 2024·3 cites·10 claims
- 0698US11925676B2Method for treating neoplasia with an anti-CD38 antibody and an IL-15:IL-15R complexALTOR BIOSCIENCE LLC·Filed 2023·Granted Mar 12, 2024·3 cites·23 claims
- 0798US11890323B2Method of treating cancer with composition comprising IL-15-based molecules and BCGALTOR BIOSCIENCE LLC·Filed 2022·Granted Feb 6, 2024·3 cites·6 claims
- 0898US11679144B2IL-15-based molecules and methods of use thereofALTOR BIOSCIENCE LLC·Filed 2022·Granted Jun 20, 2023·6 cites·9 claims
- 0998US11673932B2Fusion molecules and IL-15 variantsALTOR BIOSCIENCE LLC·Filed 2022·Granted Jun 13, 2023·10 cites·13 claims
- 1098US11471511B2IL-15-based molecules and methods of use thereofALTOR BIOSCIENCE LLC·Filed 2020·Granted Oct 18, 2022·13 cites·7 claims
- 1198US11173191B2IL-15-based molecules and methods of use thereofALTOR BIOSCIENCE LLC·Filed 2019·Granted Nov 16, 2021·13 cites·8 claims
- 1298US10899821B2Method of treating neoplasia with a multimeric IL-15 soluble fusion moleculeALTOR BIOSCIENCE LLC·Filed 2018·Granted Jan 26, 2021·15 cites·21 claims
- 1398US10537615B2IL-15-based molecules and methods of use thereofALTOR BIOSCIENCE LLC·Filed 2018·Granted Jan 21, 2020·23 cites·7 claims
- 1498US10450359B2IL-15 variants and uses thereofALTOR BIOSCIENCE CORP·Filed 2016·Granted Oct 22, 2019·29 cites·14 claims
- 1598US10358478B2Multimeric IL-15 soluble fusion molecules and methods of making and using sameALTOR BIOSCIENCE CORP·Filed 2016·Granted Jul 23, 2019·26 cites·18 claims
- 1698US9925247B2IL-15-based molecules and methods of use thereofALTOR BIOSCIENCE CORP·Filed 2015·Granted Mar 27, 2018·37 cites·25 claims
- 1798US9464127B2Fusion molecules and IL-15 variantsALTOR BIOSCIENCE CORP·Filed 2013·Granted Oct 11, 2016·49 cites·21 claims
- 1898US9428573B2Multimeric IL-15 soluble fusion molecules and methods of making and using sameALTOR BIOSCIENCE CORP·Filed 2013·Granted Aug 30, 2016·56 cites·32 claims
- 1998US9328159B2Multimeric IL-15 soluble fusion molecules and methods of using sameALTOR BIOSCIENCE CORP·Filed 2013·Granted May 3, 2016·54 cites·9 claims
- 2098US9255141B2Multimeric IL-15 soluble fusion molecules and methods of treating neoplasia and HIV using sameWONG HING C·Filed 2013·Granted Feb 9, 2016·44 cites·16 claims
- 2198US8940289B2Fusion molecules and IL-15 variantsWONG HING C·Filed 2012·Granted Jan 27, 2015·46 cites·8 claims
- 2298US8507222B2Multimeric IL-15 soluble fusion molecules and methods of making and using sameWONG HING C·Filed 2011·Granted Aug 13, 2013·109 cites·6 claims
- 2398US8492118B2Fusion molecules and IL-15 variantsWONG HING C·Filed 2008·Granted Jul 23, 2013·52 cites·26 claims
- 2498US8163879B2Fusion molecules and IL-15 variantsWONG HING C·Filed 2010·Granted Apr 24, 2012·81 cites·9 claims
- 2597US11612645B2IL-15-based fusions to IL-12 and IL-18ALTOR BIOSCIENCE LLC·Filed 2022·Granted Mar 28, 2023·6 cites·4 claims
- 2697US11571470B2IL-15-based fusions to IL-12 and IL-18ALTOR BIOSCIENCE LLC·Filed 2021·Granted Feb 7, 2023·6 cites·5 claims
- 2797US11498950B1Fusion molecules and IL-15 variantsALTOR BIOSCIENCE LLC·Filed 2019·Granted Nov 15, 2022·9 cites·7 claims
- 2897US11369679B2Multimeric IL-15-based moleculesALTOR BIOSCIENCE LLC·Filed 2020·Granted Jun 28, 2022·10 cites·16 claims
- 2997US11318201B2Multimeric IL-15-based moleculesALTOR BIOSCIENCE LLC·Filed 2021·Granted May 3, 2022·13 cites·9 claims
- 3097US11129883B2IL-15-based fusions to IL-12 and IL-18ALTOR BIOSCIENCE LLC·Filed 2018·Granted Sep 28, 2021·16 cites·14 claims
- 3197US10865230B2Construction and characterization of multimeric IL-15-based molecules with CD3 binding domainsALTOR BIOSCIENCE CORP·Filed 2017·Granted Dec 15, 2020·21 cites·15 claims
- 3296US11975059B2IL-15-based fusions to IL-12 and IL-18ALTOR BIOSCIENCE LLC·Filed 2023·Granted May 7, 2024·2 cites·14 claims
- 3396US11365231B2Interleukin 15 (IL-15) variantsALTOR BIOSCIENCE LLC·Filed 2019·Granted Jun 21, 2022·10 cites·7 claims
- 3496US9593152B2Methods of treating disease with fusion molecules comprising IL-15 variantsALTOR BIOSCIENCE CORP·Filed 2014·Granted Mar 14, 2017·23 cites·5 claims
- 3596US5516637AMethod involving display of protein binding pairs on the surface of bacterial pili and bacteriophageDADE INT INC·Filed 1994·Granted May 14, 1996·1.1k cites·14 claims
- 3694US11872272B2IL-15-based fusions to IL-12 and IL-18ALTOR BIOSCIENCE LLC·Filed 2023·Granted Jan 16, 2024·1 cites·7 claims
- 3793US12318432B2BCG and IL-15 based moleculesALTOR BIOSCIENCE LLC·Filed 2024·Granted Jun 3, 2025·0 cites·3 claims
- 3893US12268732B2IL-15-based molecules with anti-CD20 antibody and methods of useALTOR BIOSCIENCE LLC·Filed 2024·Granted Apr 8, 2025·0 cites·5 claims
- 3993US12268731B2Compositions comprising IL-15N72D-based molecules and bacillus calmette-guerin (BCG)ALTOR BIOSCIENCE LLC·Filed 2024·Granted Apr 8, 2025·0 cites·11 claims
- 4093US11053299B2SuperkineIMMUNITY BIO INC·Filed 2019·Granted Jul 6, 2021·16 cites·18 claims
- 4193US6232445B1Soluble MHC complexes and methods of use thereofSUNOL MOLECULAR CORP·Filed 1997·Granted May 15, 2001·110 cites·20 claims
- 4293US5869270ASingle chain MHC complexes and uses thereofSUNOL MOLECULAR CORP·Filed 1996·Granted Feb 9, 1999·95 cites·38 claims
- 4393US2024299498A1Method for stimulating tumor-infiltrating lymphocytes with an il-15:il-15r complexALTOR BIOSCIENCE LLC·Filed 2024·Application pending·0 cites
- 4492US12097244B2Methods of treating a neoplasia with IL-15-based molecules and CTLA-4 antibodyALTOR BIOSCIENCE LLC·Filed 2023·Granted Sep 24, 2024·0 cites·23 claims
- 4592US2025066442A1Fusion molecules and il-15 variantsALTOR BIOSCIENCE LLC·Filed 2024·Application pending·0 cites
- 4691US12371472B2Multimeric IL-15 soluble fusion molecules and methods of making and using sameALTOR BIOSCIENCE LLC·Filed 2023·Granted Jul 29, 2025·0 cites·11 claims
- 4791US12233116B2IL-15-based fusions to IL-12 and IL-18ALTOR BIOSCIENCE LLC·Filed 2024·Granted Feb 25, 2025·0 cites·6 claims
- 4890US7141656B2MHC complexes and uses thereofALTOR BIOSCIENCE CORP·Filed 2001·Granted Nov 28, 2006·32 cites·28 claims
- 4990US6306605B1Methods for making recombinant cellsSUNOL MOLECULAR CORP·Filed 2000·Granted Oct 23, 2001·22 cites·22 claims
- 5089US12186372B2IL-15-based molecules and methods of treating a neoplasiaALTOR BIOSCIENCE LLC·Filed 2023·Granted Jan 7, 2025·0 cites·21 claims
Showing the top 50 of 74 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Peter Rhode files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →